T0	Participants 48 68	psychotic depression
T1	Participants 214 245	patients with major depression.
T2	Participants 325 374	major depression with psychotic features (MDpsy).
T3	Participants 462 574	MDpsy in patients who participated in the STOPD-PD study, a randomized, double-blind, clinical trial comparing a
T4	Participants 910 1045	subjects with a history of no prior treatment or inadequate treatment who were treated with a combination of olanzapine and sertraline.
T5	Participants 1083 1205	subjects who had previously failed to respond to an antidepressant alone and who were treated with olanzapine monotherapy.
T6	Participants 1248 1353	subjects who had previously failed to respond to a combination of an antipsychotic and an antidepressant.
T7	Participants 1482 1502	patients with MDpsy.